SCHEMBL5919

SCHEMBL5919

FC(F)(F)Oc1ccc(N2CC[C@]3(CC[C@@H](Sc4ccccc4)CC3)C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 13/20 0.41
CHRM4 P08173 4/20 0.40
DRD3 P35462 1/20 0.38
OPRL1 P41146 1/20 0.37
EPHX2 P34913 1/20 0.37
FFAR1 O14842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5888 0.80 EPHX2 (0.49) FFAR4DRD3EPHX2
SCHEMBL1588919 0.77 LIPE (0.58) OPRL1
SCHEMBL9942 0.77 LIPE (0.58) OPRL1
SCHEMBL9943 0.77 LIPE (0.58) OPRL1
SCHEMBL26552871 0.76 ALDH1A1 (0.47) EPHX2
SCHEMBL622213 0.74 FFAR4 (0.46) FFAR4DRD3EPHX2
SCHEMBL621231 0.74 EPHX2 (0.47) FFAR4CHRM4EPHX2
SCHEMBL5287 0.73 CHRM4 (0.44) CHRM4EPHX2
SCHEMBL24227415 0.73 USP2 (0.46) FFAR4OPRL1EPHX2
SCHEMBL621627 0.73 DRD2 (0.52) DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP claimed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO claimed